Art

J-GLOBAL ID：201202243049198296   Reference number：12A1571324

Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Japanese Men with Benign Prostatic Hyperplasia: Results from a 12-week Placebo-controlled Dose-finding Study with a 42-week Open-label Extension

前立腺肥大症の日本人男性におけるタダラフィル投与による下部尿路症状治療:12週間のプラセボ対照用量設定試験の結果

Author (5)： TAKEDA Masayuki (Univ. Yamanashi, Chuo, JPN) ,  NISHIZAWA Osamu (Shinshu Univ. School of Medicine, Matsumoto, JPN) ,  IMAOKA Takeshi (Eli Lilly Japan K.K., Kobe, JPN) ,  MORISAKI Yoji (Eli Lilly Japan K.K., Kobe, JPN) ,  VIKTRUP Lars (Eli Lilly and Co., Indianapolis, USA)
Material： LUTS  (Lower Urinary Tract Symptoms)
Volume： 4  Issue： 3  Page： 110-119  Publication year： Sep. 2012 
JST Material Number： W2283A  ISSN： 1757-5664  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： *prostatic hypertrophy ,...
Semi thesaurus term： Japanese ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A1571324&from=J-GLOBAL&jstjournalNo=W2283A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for urogenital diseases  (GM05020V)

Substance index (1)： Tadalafil

Reference (28)：

• Lepor H. Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Rev Urol 2004; 6 (Suppl 9): S3-10.
• Abrams P, Cardozo L, Fall M et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003; 61: 37-49.
• American Urological Association Practice Guidelines Committee. Chapter 1: Guideline on the management of benign prostatic hyperplasia (BPH). American Urological Association Guideline: Management of Benign Prostatic Hyperplasia (BPH). American Urological Association Education and Research, Inc., 2010.[Cited 14 Feb 2012]. Available from URL: http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=bph.
• McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care 2006; 12: S122-8.
• Tsukamoto T, Kumamoto Y, Masumori N et al. Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol 1995; 154: 391-5.

Terms in the title (11)： 前立腺肥大症 ,  日本人 ,  男性 ,  タダラフィル ,  投与 ,  下部尿路症状 ,  治療 ,  プラセボ ,  対照 ,  用量 ,  試験